AbbVie, Inc. (ABBV)
276.40
+3.98
(+1.46%)
USD |
NYSE |
Oct 09, 16:00
276.00
-0.40
(-0.14%)
After-Hours: 18:18
AbbVie Free Cash Flow : 18.21B for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.21B |
| March 31, 2026 | 19.98B |
| December 31, 2025 | 17.82B |
| September 30, 2025 | 19.68B |
| June 30, 2025 | 18.24B |
| March 31, 2025 | 15.38B |
| December 31, 2024 | 17.83B |
| September 30, 2024 | 15.58B |
| June 30, 2024 | 17.74B |
| March 31, 2024 | 21.85B |
| December 31, 2023 | 22.02B |
| September 30, 2023 | 24.73B |
| June 30, 2023 | 24.80B |
| March 31, 2023 | 23.52B |
| December 31, 2022 | 24.25B |
| September 30, 2022 | 21.92B |
| June 30, 2022 | 22.21B |
| March 31, 2022 | 22.05B |
| December 31, 2021 | 21.99B |
| September 30, 2021 | 20.48B |
| June 30, 2021 | 18.37B |
| March 31, 2021 | 16.59B |
| December 31, 2020 | 15.59B |
| September 30, 2020 | 15.33B |
| June 30, 2020 | 14.29B |
| Date | Value |
|---|---|
| March 31, 2020 | 13.55B |
| December 31, 2019 | 12.77B |
| September 30, 2019 | 12.93B |
| June 30, 2019 | 12.60B |
| March 31, 2019 | 13.17B |
| December 31, 2018 | 12.79B |
| September 30, 2018 | 11.92B |
| June 30, 2018 | 10.82B |
| March 31, 2018 | 9.95B |
| December 31, 2017 | 9.431B |
| September 30, 2017 | 8.456B |
| June 30, 2017 | 6.652B |
| March 31, 2017 | 6.562B |
| December 31, 2016 | 6.562B |
| September 30, 2016 | 6.953B |
| June 30, 2016 | 7.64B |
| March 31, 2016 | 7.57B |
| December 31, 2015 | 7.003B |
| September 30, 2015 | 4.454B |
| June 30, 2015 | 4.032B |
| March 31, 2015 | 3.89B |
| December 31, 2014 | 2.937B |
| September 30, 2014 | 4.762B |
| June 30, 2014 | 4.821B |
| March 31, 2014 | 5.164B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.49B |
| Gilead Sciences, Inc. | 12.94B |
| Amgen, Inc. | 10.18B |
| Regeneron Pharmaceuticals, Inc. | 3.575B |
| Johnson & Johnson | 22.61B |